LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 52

Search options

  1. Article: Optimierte Patientenversorgung - Herzinsuffizienz 2014: Telemedizin mit beträchtlichem Potenzial

    Hagen, Norbert / Bosch, Ralph F.

    Kompendium ... Herz-Kreislauf

    2014  Volume 10, Issue 1, Page(s) 32

    Language German
    Document type Article
    ZDB-ID 2279135-8
    ISSN 1439-0841 ; 1860-4730
    Database Current Contents Medicine

    More links

    Kategorien

  2. Article ; Online: Impedance-based remote monitoring in patients with heart failure and concomitant chronic kidney disease.

    Wintrich, Jan / Pavlicek, Valerie / Brachmann, Johannes / Bosch, Ralph / Butter, Christian / Oswald, Hanno / Rybak, Karin / Mahfoud, Felix / Böhm, Michael / Ukena, Christian

    ESC heart failure

    2023  Volume 10, Issue 5, Page(s) 3011–3018

    Abstract: Aims: Remote monitoring (RM) of thoracic impedance represents an early marker of pulmonary congestion in heart failure (HF). Chronic kidney disease (CKD) may promote fluid overload in HF patients. We investigated whether concomitant CKD affected the ... ...

    Abstract Aims: Remote monitoring (RM) of thoracic impedance represents an early marker of pulmonary congestion in heart failure (HF). Chronic kidney disease (CKD) may promote fluid overload in HF patients. We investigated whether concomitant CKD affected the efficacy of impedance-based RM in the OptiLink HF trial.
    Methods and results: Among HF patients included in the OptiLink HF trial, time to the first cardiovascular hospitalization and all-cause death according to the presence of concomitant CKD was analysed. CKD was defined as GFR < 60 mL/min/1.73 m
    Conclusions: The presence of CKD in HF patients led to a higher number of telemedical alert transmissions and increased the risk of the primary endpoint. Inappropriate handling of alert transmission was commonly observed in patients with chronic HF and CKD. Guidance of HF management by impedance-based RM significantly decreased primary event rates in patients without CKD, but not in patients with CKD.
    MeSH term(s) Humans ; Chronic Disease ; Electric Impedance ; Heart Failure/complications ; Heart Failure/epidemiology ; Heart Failure/therapy ; Hospitalization ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/epidemiology ; Clinical Trials as Topic
    Language English
    Publishing date 2023-08-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2814355-3
    ISSN 2055-5822 ; 2055-5822
    ISSN (online) 2055-5822
    ISSN 2055-5822
    DOI 10.1002/ehf2.14387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2.

    Strand, Vibeke / Van den Bosch, Filip / Ranza, Roberto / Leung, Ying-Ying / Drescher, Edit / Zueger, Patrick / Saffore, Christopher D / Lertratanakul, Apinya / Lippe, Ralph / Nash, Peter

    Rheumatology and therapy

    2021  Volume 8, Issue 4, Page(s) 1827–1844

    Abstract: ... of life (SF-36 physical (PCS) and mental (MCS) component summary and domain scores), fatigue (FACIT-F ...

    Abstract Introduction: Psoriatic arthritis (PsA) has a major impact on health-related quality of life (HRQOL) and other patient-reported outcomes (PROs), important components in the assessment of therapeutic efficacy. We evaluated the impact of upadacitinib on PROs in PsA patients with inadequate responses or intolerance to biologic disease-modifying anti-rheumatic drugs (bDMARD-IR).
    Methods: Patients enrolled in the phase 3 SELECT-PsA 2 randomized controlled trial (RCT) received 56 weeks of oral upadacitinib 15 mg QD, upadacitinib 30 mg QD, or placebo switched to either dose of upadacitinib at week 24. PROs included patient global assessment of disease activity (PtGA), pain, physical function (HAQ-DI), health-related quality of life (SF-36 physical (PCS) and mental (MCS) component summary and domain scores), fatigue (FACIT-F), psoriasis symptom severity (SAPS), and work productivity (WPAI). Mean changes from baseline in PROs, improvements ≥ minimum clinically important differences (MCID) and scores ≥ normative values, and maintenance of improvements were assessed.
    Results: At weeks 12 and 24, patients treated with either upadacitinib dose reported statistically and nominally significant improvements from baseline across all PROs versus placebo (p ≤ 0.05), except the WPAI absenteeism domain, which were maintained or further improved to week 56. A significantly greater proportion of patients receiving either upadacitinib dose reported improvements ≥ MCID and scores ≥ normative values versus placebo (nominal p ≤ 0.01) in most PROs at weeks 12 and 24, with clinically meaningful improvements continuing to week 56. Improvements ≥ MCID were reported as early as week 2 in PtGA, pain, and HAQ-DI.
    Conclusions: Upadacitinib provides rapid, clinically meaningful, and sustained improvements in PROs reported by bDMARD-IR PsA patients. SELECT-PsA 2 ClinicalTrials.gov number, NCT03104374.
    Language English
    Publishing date 2021-10-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2783278-8
    ISSN 2198-6584 ; 2198-6576
    ISSN (online) 2198-6584
    ISSN 2198-6576
    DOI 10.1007/s40744-021-00377-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.

    Östör, Andrew / Van den Bosch, Filip / Papp, Kim / Asnal, Cecilia / Blanco, Ricardo / Aelion, Jacob / Carter, Kyle / Stakias, Vassilis / Lippe, Ralph / Drogaris, Leonidas / Soliman, Ahmed M / Chen, Michael M / Padilla, Byron / Kivitz, Alan

    Rheumatology and therapy

    2024  

    Abstract: Introduction: Long-term therapeutic options providing durable response and tolerability are needed for psoriatic arthritis (PsA). The ongoing KEEPsAKE 2 trial is evaluating risankizumab treatment in patients with active PsA who previously had inadequate ...

    Abstract Introduction: Long-term therapeutic options providing durable response and tolerability are needed for psoriatic arthritis (PsA). The ongoing KEEPsAKE 2 trial is evaluating risankizumab treatment in patients with active PsA who previously had inadequate response/intolerance to ≥ 1 conventional synthetic disease-modifying antirheumatic drug (csDMARD-IR) and/or 1-2 biologic DMARDs (bDMARD-IR). Herein, we report results through 100 weeks of treatment.
    Methods: KEEPsAKE 2 is a global phase 3 trial. Patients with active PsA were randomized 1:1 to double-blind subcutaneous risankizumab 150 mg or placebo (weeks 0, 4, and 16). At week 24, all patients received open-label risankizumab every 12 weeks until end of study. Efficacy endpoints included achieving ≥ 20% improvement in PsA symptoms using American College of Rheumatology criteria (ACR20), attaining minimal disease activity (MDA; meeting ≥ 5/7 criteria of low disease activity and extent), and improving in other measures.
    Results: At the cutoff date, 345/443 (77.9%) patients were ongoing in the study. ACR20 was achieved in 57.1% and 52.5% of the continuous risankizumab and placebo/risankizumab cohorts, respectively, at week 100 and in 60.0% and 55.8%, respectively, at week 52. In week 52 responders, maintenance of ACR20 at week 100 was achieved in 74.8% (continuous risankizumab) and 78.7% (placebo/risankizumab) of patients. In the continuous risankizumab and placebo/risankizumab cohorts, respectively, MDA was achieved by 33.0% and 33.3% of patients at week 100 and by 27.2% and 33.8% at week 52. Among MDA responders at week 52, maintenance of MDA response was achieved by 83.6% and 73.0% of the continuous risankizumab and placebo/risankizumab cohorts, respectively. Risankizumab was well tolerated through week 100.
    Conclusions: Risankizumab demonstrated durable efficacy and tolerability through 100 weeks; most patients who achieved ACR20 and MDA responses at week 52 maintained this achievement through week 100. There were no new safety signals in patients who had csDMARD-IR and bDMARD-IR.
    Trial registration: ClinicalTrials.gov NCT03671148.
    Language English
    Publishing date 2024-03-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2783278-8
    ISSN 2198-6584 ; 2198-6576
    ISSN (online) 2198-6584
    ISSN 2198-6576
    DOI 10.1007/s40744-024-00657-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Prevalence of inflicted and neglectful femur shaft fractures in young children in national level I trauma centers.

    Loos, Marie-Louise H J / Bakx, Roel / Allema, J H / Bloemers, Frank W / Ten Bosch, Jan A / Edwards, Michael J R / Hulscher, Jan B F / Keyzer-Dekker, Claudia M G / Krug, Egbert / de Ridder, Victor A / Spanjersberg, W Richard / Teeuw, Arianne H / Theeuwes, Hilco P / de Vries, Selena / de Wit, Ralph / van Rijn, Rick R

    Pediatric radiology

    2022  Volume 52, Issue 12, Page(s) 2359–2367

    Abstract: Background: The prevalence of inflicted femur fractures in young children varies (1.5-35.2%), but these data are based on small retrospective studies with high heterogeneity. Age and mobility of the child seem to be indicators of inflicted trauma.: ... ...

    Abstract Background: The prevalence of inflicted femur fractures in young children varies (1.5-35.2%), but these data are based on small retrospective studies with high heterogeneity. Age and mobility of the child seem to be indicators of inflicted trauma.
    Objective: This study describes other factors associated with inflicted and neglectful trauma that can be used to distinguish inflicted and neglectful from accidental femur fractures.
    Materials and methods: This retrospective study included children (0-6 years) who presented with an isolated femur fracture at 1 of the 11 level I trauma centers in the Netherlands between January 2010 and January 2016. Outcomes were classified based on the conclusions of the Child Abuse and Neglect teams or the court. Cases in which conclusions were unavailable and there was no clear accidental cause were reviewed by an expert panel.
    Results: The study included 328 children; 295 (89.9%) cases were classified as accidental trauma. Inflicted trauma was found in 14 (4.3%), while 19 (5.8%) were cases of neglect. Indicators of inflicted trauma were age 0-5 months (29%, positive likelihood ratio [LR +] 8.35), 6-12 months (18%, LR + 5.98) and 18-23 months (14%, LR + 3.74). Indicators of neglect were age 6-11 months (18%, LR + 4.41) and age 18-23 months (8%, LR + 1.65). There was no difference in fracture morphology among groups.
    Conclusion: It is unlikely that an isolated femur fracture in ambulatory children age > 24 months is caused by inflicted trauma/neglect. Caution is advised in children younger than 24 months because that age is the main factor associated with inflicted trauma/neglect and inflicted femur fractures.
    MeSH term(s) Child ; Humans ; Infant ; Child, Preschool ; Infant, Newborn ; Trauma Centers ; Femoral Fractures/diagnostic imaging ; Femoral Fractures/epidemiology ; Retrospective Studies ; Prevalence ; Femur/injuries ; Child Abuse/diagnosis
    Language English
    Publishing date 2022-05-07
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124459-0
    ISSN 1432-1998 ; 0301-0449
    ISSN (online) 1432-1998
    ISSN 0301-0449
    DOI 10.1007/s00247-022-05378-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The prevalence of non-accidental trauma among children with polytrauma: A nationwide level-I trauma centre study.

    Loos, Marie-Louise H J / van Rijn, Rick R / Krug, Egbert / Bloemers, Frank W / Ten Bosch, Jan A / Bossuyt, P M M / Edwards, Michael J R / Greeven, Alexander P A / Hulscher, Jan B F / Keyzer-Dekker, Claudia M G / de Ridder, Victor A / Spanjersberg, W Richard / Teeuw, Arianne H / Theeuwes, Hilco P / de Vries, Selena / de Wit, Ralph / Bakx, Roel

    Journal of forensic and legal medicine

    2022  Volume 90, Page(s) 102386

    Abstract: Objective: We aimed to investigate the prevalence and characteristics of non-accidental trauma (NAT) in children with polytrauma treated at level-I trauma centres (TC).: Summary of background: Data 6-10% Of children who present at the emergency ... ...

    Abstract Objective: We aimed to investigate the prevalence and characteristics of non-accidental trauma (NAT) in children with polytrauma treated at level-I trauma centres (TC).
    Summary of background: Data 6-10% Of children who present at the emergency department with injuries, sustain polytrauma. Polytrauma may result from either accidental (AT) or NAT, i.e. inflicted or neglect. The prevalence of NAT among children with polytrauma is currently unclear.
    Methods: This is a retrospective study that included children (0-18 years) with an Injury Severity Score >15, who presented at one of the 11 Level-I trauma centers (TC) in the Netherlands between January 1, 2010 and January 1, 2016. Outcomes were classified based on the conclusions of the Child Abuse and Neglect-team. Cases in which conclusions were unavailable and there was no clear accidental cause of injuries were reviewed by an expert panel.
    Results: The study included 1623 children, 1452 (89%) were classified as AT, 171 (11%) as NAT; 39 (2,4%) inflicted and 132 (8,1%) neglect. Of pre-school aged children (<5 years) 41% sustained NAT (OR26.73, 95%CI 17.70-40.35), 35/342 (10%) inflicted and 104/342 (31%) neglect. Admission due to 'cardiopulmonary arrest' was the result of inflicted trauma (30% vs 0%,p < 0.001). NAT had a higher mortality rate (16% vs 10%, p = 0.006). Indicators of NAT were: (near-)drowning (OR10.74, 95%CI 5.94-19.41), burn (OR8.62, 95%CI 4.08-18.19) and fall from height (OR2.18, 95%CI 1.56-3.02).
    Conclusions: NAT was the cause of polytrauma in 11% of children in our nationwide level-I TC study; 41% of these polytrauma were the result of NAT experienced by preschool-aged children. Our data show the importance of awareness for NAT.
    MeSH term(s) Child ; Child Abuse ; Child, Preschool ; Humans ; Infant ; Injury Severity Score ; Multiple Trauma/epidemiology ; Prevalence ; Retrospective Studies ; Trauma Centers
    Language English
    Publishing date 2022-06-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2268721-X
    ISSN 1878-7487 ; 1752-928X
    ISSN (online) 1878-7487
    ISSN 1752-928X
    DOI 10.1016/j.jflm.2022.102386
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intensified ambulatory cardiology care: effects on mortality and hospitalisation-a comparative observational study.

    Sawicki, Olga A / Mueller, Angelina / Glushan, Anastasiya / Breitkreuz, Thorben / Wicke, Felix S / Karimova, Kateryna / Gerlach, Ferdinand M / Wensing, Michel / Smetak, Norbert / Bosch, Ralph F / Beyer, Martin

    Scientific reports

    2020  Volume 10, Issue 1, Page(s) 14695

    Abstract: Since 2010, an intensified ambulatory cardiology care programme has been implemented in southern Germany. To improve patient management, the structure of cardiac disease management was improved, guideline-recommended care was supported, new ambulatory ... ...

    Abstract Since 2010, an intensified ambulatory cardiology care programme has been implemented in southern Germany. To improve patient management, the structure of cardiac disease management was improved, guideline-recommended care was supported, new ambulatory medical services and a morbidity-adapted reimbursement system were set up. Our aim was to determine the effects of this programme on the mortality and hospitalisation of enrolled patients with cardiac disorders. We conducted a comparative observational study in 2015 and 2016, based on insurance claims data. Overall, 13,404 enrolled patients with chronic heart failure (CHF) and 19,537 with coronary artery disease (CAD) were compared, respectively, to 8,776 and 16,696 patients that were receiving usual ambulatory cardiology care. Compared to the control group, patients enrolled in the programme had lower mortality (Hazard Ratio: 0.84; 95% CI: 0.77-0.91) and fewer all-cause hospitalisations (Rate Ratio: 0.94; 95% CI: 0.90-0.97). CHF-related hospitalisations in patients with CHF were also reduced (Rate Ratio: 0.76; 95% CI: 0.69-0.84). CAD patients showed a similar reduction in mortality rates (Hazard Ratio: 0.81; 95% CI: 0.76-0.88) and all-cause hospitalisation (Rate Ratio: 0.94; 95% CI: 0.91-0.97), but there was no effect on CAD-related hospitalisation. We conclude that intensified ambulatory care reduced mortality and hospitalisation in cardiology patients.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Ambulatory Care/methods ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy ; Disease Management ; Female ; Heart Failure/mortality ; Heart Failure/therapy ; Hospitalization ; Humans ; Male ; Middle Aged ; Young Adult
    Language English
    Publishing date 2020-09-07
    Publishing country England
    Document type Comparative Study ; Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-71770-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Intensified ambulatory cardiology care

    Olga A. Sawicki / Angelina Mueller / Anastasiya Glushan / Thorben Breitkreuz / Felix S. Wicke / Kateryna Karimova / Ferdinand M. Gerlach / Michel Wensing / Norbert Smetak / Ralph F. Bosch / Martin Beyer

    Scientific Reports, Vol 10, Iss 1, Pp 1-

    effects on mortality and hospitalisation—a comparative observational study

    2020  Volume 8

    Abstract: Abstract Since 2010, an intensified ambulatory cardiology care programme has been implemented in southern Germany. To improve patient management, the structure of cardiac disease management was improved, guideline-recommended care was supported, new ... ...

    Abstract Abstract Since 2010, an intensified ambulatory cardiology care programme has been implemented in southern Germany. To improve patient management, the structure of cardiac disease management was improved, guideline-recommended care was supported, new ambulatory medical services and a morbidity-adapted reimbursement system were set up. Our aim was to determine the effects of this programme on the mortality and hospitalisation of enrolled patients with cardiac disorders. We conducted a comparative observational study in 2015 and 2016, based on insurance claims data. Overall, 13,404 enrolled patients with chronic heart failure (CHF) and 19,537 with coronary artery disease (CAD) were compared, respectively, to 8,776 and 16,696 patients that were receiving usual ambulatory cardiology care. Compared to the control group, patients enrolled in the programme had lower mortality (Hazard Ratio: 0.84; 95% CI: 0.77–0.91) and fewer all-cause hospitalisations (Rate Ratio: 0.94; 95% CI: 0.90–0.97). CHF-related hospitalisations in patients with CHF were also reduced (Rate Ratio: 0.76; 95% CI: 0.69–0.84). CAD patients showed a similar reduction in mortality rates (Hazard Ratio: 0.81; 95% CI: 0.76–0.88) and all-cause hospitalisation (Rate Ratio: 0.94; 95% CI: 0.91–0.97), but there was no effect on CAD-related hospitalisation. We conclude that intensified ambulatory care reduced mortality and hospitalisation in cardiology patients.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2020-09-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Devicetherapie bei Herzinsuffizienz

    Bosch, Ralph F. / Krause-Allmendinger, Hellmut / Kruck, Irmtraut

    Kompendium ... Herz-Kreislauf

    2011  Volume 7, Issue 1, Page(s) 16

    Language German
    Document type Article
    ZDB-ID 2279135-8
    ISSN 1439-0841 ; 1860-4730
    Database Current Contents Medicine

    More links

    Kategorien

  10. Article ; Online: Immunosuppression response to the neonicotinoid insecticide thiacloprid in females and males of the red mason bee Osmia bicornis L.

    Brandt, Annely / Hohnheiser, Birgitta / Sgolastra, Fabio / Bosch, Jordi / Meixner, Marina Doris / Büchler, Ralph

    Scientific reports

    2020  Volume 10, Issue 1, Page(s) 4670

    Abstract: Solitary bees are frequently exposed to pesticides, which are considered as one of the main stress factors that may lead to population declines. A strong immune defence is vital for the fitness of bees. However, the immune system can be weakened by ... ...

    Abstract Solitary bees are frequently exposed to pesticides, which are considered as one of the main stress factors that may lead to population declines. A strong immune defence is vital for the fitness of bees. However, the immune system can be weakened by environmental factors that may render bees more vulnerable to parasites and pathogens. Here we demonstrate for the first time that field-realistic concentrations of the commonly used neonicotinoid insecticide thiacloprid can severely affect the immunocompetence of Osmia bicornis. In detail, males exposed to thiacloprid solutions of 200 and 555 µg/kg showed a reduction in hemocyte density. Moreover, functional aspects of the immune defence - the antimicrobial activity of the hemolymph - were impaired in males. In females, however, only a concentration of 555 µg/kg elicited similar immunosuppressive effects. Although males are smaller than females, they consumed more food solution. This leads to a 2.77 times higher exposure in males, probably explaining the different concentration thresholds observed between the sexes. In contrast to honeybees, dietary exposure to thiacloprid did not affect melanisation or wound healing in O. bicornis. Our results demonstrate that neonicotinoid insecticides can negatively affect the immunocompetence of O. bicornis, possibly leading to an impaired disease resistance capacity.
    MeSH term(s) Animals ; Bees/drug effects ; Bees/immunology ; Biomarkers ; Cell Count ; Feeding Behavior/drug effects ; Female ; Hemocytes/drug effects ; Hemolymph ; Immunosuppressive Agents/pharmacology ; Insecticides/pharmacology ; Male ; Neonicotinoids/pharmacology ; Thiazines/pharmacology
    Chemical Substances Biomarkers ; Immunosuppressive Agents ; Insecticides ; Neonicotinoids ; Thiazines ; thiacloprid (DSV3A944A4)
    Language English
    Publishing date 2020-03-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-61445-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top